RQ Bio welcomes positive CHMP opinion on Kavigale for prevention of COVID-19 in immunocompromised individualsKavigale (sipavibart; AZD3152) is a ...

Agreement supports the research and development of up to five novel therapeutic antibodies identified through Alchemab's antibody discovery platform. CAMBRIDGE, England, Jan. 9, 2025 /PRNewswire/ ...

We’ll do an IgE test to figure out what’s causing those reactions.” When my doctor said those words, I nodded like I knew ...

Banner Health encourages pregnant women to reduce their newborn’s risk of developing a severe illness through vaccination. Respiratory syncytial virus (RSV) season typically peaks in the winter and ...

To identify this year’s Drugs to Watch 2025 list, Clarivate drew from expertise from over 160 Clarivate analysts covering ...

Subcutaneous ocrelizumab (SC OCR) was found to be safe for patients with relapsing and primary progressive multiple sclerosis ...

Five years on from the first news of COVID, recent reports of an obscure respiratory virus in China may understandably raise ...

Fighting off infections when one has a chronic disease is a common problem, and during the COVID-19 pandemic that scenario ...

Study reveals surprising connection between common childhood virus CMV and Alzheimer's disease, offering new insights into ...

Araris will use its linker technology to generate multi-warhead ADCs for “undisclosed targets” provided by Chugai.

Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC) (the “Company”), comments on the many viruses that could cause pandemics that are going around already.